FIELD: medicine.
SUBSTANCE: specified kit contains a dried complex including tissue factor/phospholipid and a dried mixture containing thrombin substratum and CaCl2. There is disclosed method for preparing the dried complex including tissue factor (TF/phospholipid (PL). There is offered method for preparing said dried mixture containing thrombin substratum and CaCl2. Besides, there is described method for measuring thrombin formation in a sample by measuring the concentration of thrombin.
EFFECT: invention allows detecting kinetic changes in thrombin formations after introduction of agents action of which is not related to inhibitor.
22 cl, 5 dwg, 2 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COLLAGEN-BASED HEMOSTATIC SPONGE, METHOD FOR ITS OBTAINING, BANDAGE FOR WOUNDS INCLUDING SUCH A SPONGE AND KIT FOR PREPARING BANDAGE FOR WOUNDS | 1997 |
|
RU2193897C2 |
| METHOD FOR OBTAINING A LIOPHILIZED PREPARATION OF AN ACTIVATED PROTROMBIN COMPLEX HAVING VIII-SHUNTING ACTIVITY FACTOR | 2017 |
|
RU2648517C1 |
| NOVEL CHEMILUMINESCENT SUBSTRATES FOR Xa FACTOR | 2019 |
|
RU2820234C2 |
| PHOSPHOLIPID-ENRICHED VESICLES BEARING TISSUE FACTOR HAVING HAEMOSTATIC ACTIVITY AND USE THEREOF | 2011 |
|
RU2595406C2 |
| FACTOR II AND FIBRINOGEN FOR TREATMENT OF HAEMOSTATIC DISORDERS | 2011 |
|
RU2606155C2 |
| METHOD OF PRODUCING POWDER CONTAINING PROTEIN WHICH IS HUMAN BLOOD COAGULATION FACTOR AND LACTIC ACID-BASED POLYMER | 2016 |
|
RU2702740C2 |
| PHARMACEUTICAL PREPARATION THAT IS ABLE TO ACCELERATE BLOOD COAGULATION PROCESS, A METHOD OF BLOOD COAGULATION ACCELERATION IN VITRO, USE OF AN INHIBITOR OF EPI-ACTIVITY AS A SUBSTANCE ACCELERATING BLOOD COAGULATION PROCESS | 1991 |
|
RU2127600C1 |
| METHOD OF CONTROLLING ANTICOAGULANT THERAPY | 2012 |
|
RU2607658C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VIIA AND FACTOR XIII | 2001 |
|
RU2272648C2 |
| COMBINED APPLICATION OF FACTOR VII POLYPEPTIDES AND FACTOR VIII POLYPEPTIDES | 2002 |
|
RU2311923C2 |
